Adma Biologics (ADMA) Gross Margin (2011 - 2025)
Adma Biologics (ADMA) posted Gross Margin of 63.82% for Q4 2025, up 13.27% on a QoQ basis from 56.34% in Q3 2025, and up 994.0% year-over-year from 5.83% in Q4 2024.
Adma Biologics (ADMA) Gross Margin (2011 - 2025) Analysis & Trends
Adma Biologics' Gross Margin history runs 13 years deep, the most recent figure standing at 63.82% for Q4 2025.
- Quarterly Gross Margin rose 994.0% year-over-year to 63.82% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 57.39% (up 590.0% YoY) and the FY2025 annual result came in at 57.39%, up 590.0% from the prior year.
- Gross Margin was 63.82% for Q4 2025 at Adma Biologics, up from 56.34% in the prior quarter.
- Across five years, Gross Margin topped out at 63.82% in Q4 2025 and bottomed at 10.73% in Q1 2021.
- A 5-year average of 31.07% and a median of 28.69% in 2022 frame the typical range for Gross Margin.
- Peak annual rise in Gross Margin reached 5427 bps in 2021, while the deepest fall reached 9435 bps in 2021.
- Adma Biologics' Gross Margin stood at 6.38% in 2021, then surged by 344 bps to 28.36% in 2022, then jumped by 48 bps to 42.06% in 2023, then rose by 28 bps to 53.88% in 2024, then gained by 18 bps to 63.82% in 2025.
- Business Quant data shows ADMA's Gross Margin at 63.82% in Q4 2025, 56.34% in Q3 2025, and 55.11% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 63.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.82% |
| Sep 30, 2025 | 56.34% |
| Jun 30, 2025 | 55.11% |
| Mar 31, 2025 | 53.22% |
| Dec 31, 2024 | 53.88% |
| Sep 30, 2024 | 49.78% |
| Jun 30, 2024 | 53.60% |
| Mar 31, 2024 | 47.77% |
| Dec 31, 2023 | 42.06% |
| Sep 30, 2023 | 22.41% |
| Jun 30, 2023 | 27.76% |
| Mar 31, 2023 | 29.01% |
| Dec 31, 2022 | 28.36% |
| Sep 30, 2022 | 23.50% |
| Jun 30, 2022 | 10.36% |
| Mar 31, 2022 | 12.58% |
| Dec 31, 2021 | 6.38% |
| Sep 30, 2021 | 1.86% |
| Jun 30, 2021 | -5.62% |
| Mar 31, 2021 | -10.73% |